COMBINATION EFFECT OF FOSFOMYCIN AND OFLOXACIN AGAINST PSEUDOMONAS-AERUGINOSA GROWING IN A BIOFILM

被引:61
作者
KUMON, H
ONO, N
IIDA, M
NICKEL, JC
机构
[1] MEIJI SEIKA KAISHA LTD, PHARMACEUT RES CTR, YOKOHAMA, KANAGAWA 222, JAPAN
[2] QUEENS UNIV, DEPT UROL, KINGSTON, ON K7L 2V7, CANADA
关键词
D O I
10.1128/AAC.39.5.1038
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We examined the combined effect of fosfomycin and ofloxacin against Pseudomonas aeruginosa in biofilms by using an in vitro experimental system with a modified Robbins device. Sessile cells in a mature or immature biofilm, developed on a silicon disk, were used, and an ATP bioluminescence assay was employed to assess antibacterial effects. A synergistic effect of fosfomycin and ofloxacin was clearly detected when concentrations at which each drug independently produced no detectable decrease in the bioactivity of sessile cells were used. Exposure of the cells in a mature biofilm to fosfomycin at concentrations of one-eighth of the MIC to 10 times the MIC (6.25 to 500 mu g/ml) and ofloxacin at three or 10 times the MIC (18.75 or 62.5 mu g/ml) resulted in reduction of the bioactivity to 1.5 to 4.5% after 72 h. Young sessile cells in an immature biofilm were more susceptible to this combination therapy. With a combination of fosfomycin at three times the MIC and ofloxacin at three times the MIC, complete eradication was confirmed by both ATP assay and scanning electron microscopy.
引用
收藏
页码:1038 / 1044
页数:7
相关论文
共 24 条
[1]   ENHANCED ACTIVITY OF COMBINATION OF TOBRAMYCIN AND PIPERACILLIN FOR ERADICATION OF SESSILE BIOFILM CELLS OF PSEUDOMONAS-AERUGINOSA [J].
ANWAR, H ;
COSTERTON, JW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (09) :1666-1671
[2]   INTERACTION OF BIOFILM BACTERIA WITH ANTIBIOTICS IN A NOVEL INVITRO CHEMOSTAT SYSTEM [J].
ANWAR, H ;
VANBIESEN, T ;
DASGUPTA, M ;
LAM, K ;
COSTERTON, JW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (10) :1824-1826
[3]   PHARMACOKINETIC COMPARISON BETWEEN FOSFOMYCIN AND OTHER PHOSPHONIC ACID-DERIVATIVES [J].
BERGAN, T .
CHEMOTHERAPY, 1990, 36 :10-18
[4]  
COSTERTON JW, 1983, REV INFECT DIS, V5, pS867
[5]   SUSCEPTIBILITY OF PSEUDOMONAS-AERUGINOSA AND ESCHERICHIA-COLI BIOFILMS TOWARDS CIPROFLOXACIN - EFFECT OF SPECIFIC GROWTH-RATE [J].
EVANS, DJ ;
ALLISON, DG ;
BROWN, MRW ;
GILBERT, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (02) :177-184
[6]   SYNERGY OF CIPROFLOXACIN WITH FOSFOMYCIN INVITRO AGAINST PSEUDOMONAS ISOLATES FROM PATIENTS WITH CYSTIC-FIBROSIS [J].
FIGUEREDO, VM ;
NEU, HC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 (01) :41-50
[7]   ANTIBIOTIC INTERACTION AND DIFFUSION THROUGH ALGINATE AND EXOPOLYSACCHARIDE OF CYSTIC FIBROSIS-DERIVED PSEUDOMONAS-AERUGINOSA [J].
GORDON, CA ;
HODGES, NA ;
MARRIOTT, C .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 (05) :667-674
[8]   BIOMATERIAL-CENTERED INFECTION - MICROBIAL ADHESION VERSUS TISSUE INTEGRATION [J].
GRISTINA, AG .
SCIENCE, 1987, 237 (4822) :1588-1595
[9]  
HARDISSON D, 1977, CHEMOTHERAPY S1, V23, P82
[10]   PHOSPHONOMYCIN, A NEW ANTIBIOTIC PRODUCED BY STRAINS OF STREPTOMYCES [J].
HENDLIN, D ;
STAPLEY, EO ;
JACKSON, M ;
WALLICK, H ;
MILLER, AK ;
WOLF, FJ ;
MILLER, TW ;
CHAIET, L ;
KAHAN, FM ;
FOLTZ, EL ;
WOODRUFF, HB .
SCIENCE, 1969, 166 (3901) :122-&